SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-078971
Filing Date
2014-11-10
Accepted
2014-11-10 16:18:00
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-19918_110q.htm 10-Q 470360
2 EX-31.1 a14-19918_1ex31d1.htm EX-31.1 13735
3 EX-31.2 a14-19918_1ex31d2.htm EX-31.2 13722
4 EX-32.1 a14-19918_1ex32d1.htm EX-32.1 5739
5 EX-32.2 a14-19918_1ex32d2.htm EX-32.2 5779
  Complete submission text file 0001104659-14-078971.txt   4156313

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kpti-20140930.xml EX-101.INS 337478
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kpti-20140930.xsd EX-101.SCH 55294
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kpti-20140930_cal.xml EX-101.CAL 34675
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kpti-20140930_def.xml EX-101.DEF 258970
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT kpti-20140930_lab.xml EX-101.LAB 938991
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kpti-20140930_pre.xml EX-101.PRE 450268
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 141208881
SIC: 2834 Pharmaceutical Preparations